AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹7,942 Cr | ₹6,315 Cr | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr |
What is the latest Total Debt ratio of AUROBINDO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹7,942 Cr |
| Mar2024 | ₹6,315 Cr |
| Mar2023 | ₹4,862 Cr |
| Mar2022 | ₹2,373 Cr |
| Mar2021 | ₹4,972 Cr |
How is Total Debt of AUROBINDO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,942 Cr | 25.75 | |
| Mar2024 | ₹6,315 Cr | 29.90 | |
| Mar2023 | ₹4,862 Cr | 104.89 | |
| Mar2022 | ₹2,373 Cr | -52.28 | |
| Mar2021 | ₹4,972 Cr | - | |
Compare Total Debt of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹87,043.6 Cr | 1% | 9.2% | 23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1% |
9.2% |
23.1% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses